Now I have sufficient calibration data. Let me synthesize the review.

**Round 1 bracket**: Based on the three-band search, the paper sits between the weak anchor band (papers scoring 2.5–3.4, which are clearly rejected for fundamental flaws) and the strong band (papers scoring 8+, which are completely different topics). The most relevant middle-band anchors — GenoAgent (4.00, Reject), LLM4GRN (4.33, Reject), PerturbQA/SUMMER (4.60, Accept), and BioDiscoveryAgent (6.40, Accept) — bracket this paper. Initial plausible range: **4.0–5.5**.

**Round 2 narrowing**: Inside that bracket, the paper is topically closest to LLM4GRN (4.33) and GenoAgent (4.00), both rejected. It is slightly stronger than both (cleaner method, better Stage 1 ablation) but clearly weaker than BioDiscoveryAgent (6.40, which validates on multiple datasets with stronger baselines). I also read PerturbQA/SUMMER (4.60, mixed reviews with split scores of 6,3,5,6,3 leading to Accept). The HypoGeneAgent paper has comparable conceptual novelty but weaker core validation. 

**Final calibrated position**: 4.5 — between LLM4GRN (4.33, Reject) and PerturbQA (4.60, borderline Accept), and clearly below BioDiscoveryAgent (6.40).

---

## Summary

This paper proposes HypoGeneAgent, an LLM-driven framework that turns cluster annotation into a quantitative criterion for resolution selection in single-cell/Perturb-seq clustering. The core idea is to have an LLM (GPT-o3) generate multiple GO-based hypotheses for each cluster, compute intra-cluster agreement (ICS) and inter-cluster distinctiveness (ICD) from their embeddings, and combine them into a Resolution Score (RS) that can be maximized to choose the Leiden resolution parameter. The method is validated on a K562 CRISPRi Perturb-seq dataset.

## Strengths

- **Novel and well-motivated idea.** Using LLM-generated annotation consistency as a resolution-selection criterion is genuinely novel. The paper correctly identifies a real gap: heuristic resolution tuning ignores biological interpretability, and existing tools annotate clusters only after resolution is fixed. Closing this loop is a timely and valuable direction.

- **Thorough Stage 1 benchmark on GOBP gene sets.** The paper systematically ablates embedding methods (OpenAI, SapBERT, Nomic AI), prompt designs (general vs. hypothesis), LLM backbones (GPT-4o, GPT-o3, GPT-5, Gemini variants), and temperature settings on 100 curated GOBP gene sets (Section 4.3, Figs. S1–S3). This provides solid evidence that the chosen configuration (GPT-o3 + hypothesis prompt) can generate semantically plausible GO annotations, and that the model's confidence scores correlate with semantic accuracy.

- **Clear and formal metric definitions.** ICS, ICD, and RS (Eqs. 1–3) are cleanly defined and mathematically straightforward. The combination of intra-cluster agreement and inter-cluster distinctiveness into a single optimizable score is simple but reasonable.

- **Application to two clustering modalities.** The method is demonstrated on both gene-expression-level clusters and perturbation-level clusters (Figs. 3–4), showing that the framework generalizes beyond a single data modality within the same dataset.

## Weaknesses

### Major

- **Core validation gap: the Resolution Score is not shown to select a *biologically better* clustering by any independent standard.** The paper compares RS-chosen resolutions (r=0.4 GEX, r=0.5 perturbation) with those chosen by silhouette (0.5–0.6) and modularity (0.7), but never demonstrates that r=0.4 yields clusters that are more biologically meaningful. The evidence offered is circular: (i) the RS peaks at r=0.4, (ii) UMAP at r=0.4 looks clean, (iii) enrichment analysis (which uses the same GO framework) also peaks near 0.4–0.5. None of these constitutes an *external* biological ground truth. The paper would need a dataset with trusted cell-type labels (e.g., PBMC, human pancreas atlas) or known perturbation classes, and show that RS-chosen resolution achieves higher ARI to ground truth than silhouette/modularity-chosen resolutions. As written, the headline claim ("alignment with known pathway compared to classical metrics") is not supported by the evidence presented.

- **Single-dataset evaluation.** The entire Stage 2 validation rests on one K562 Perturb-seq dataset (Replogle et al., 2022). The paper claims general-purpose utility but provides no evidence on a second independent dataset (different cell type, different perturbation modality, or multi-omics). This is a significant limitation given that the method's key claim is about improving biological discovery.

- **No comparison against meaningful alternatives.** MultiK (consensus-clustering stability) is mentioned in Related Work but never used as a baseline. Only silhouette and modularity are compared. A method that claims to outperform existing resolution-selection heuristics should compare against the strongest available alternatives, not just the simplest ones.

- **The enrichment analysis comparison (Sec. 4.4.3) is a consistency check, not a validation of superiority.** The paper applies the same ICS/ICD/RS metrics to GO enrichment p-values and finds that the resulting RS also peaks at 0.4–0.5. This shows that the two approaches *agree*, not that HypoGeneAgent is better. If anything, it suggests enrichment analysis alone might suffice for resolution selection.

### Minor

- **LLM annotation accuracy is moderate and its effect on resolution selection is unexamined.** The top-1 cosine similarity to ground-truth GOBP terms is ~0.4–0.5 (Fig. S1d), and AUC at threshold 0.4 is 0.743. The paper does not analyze how errors in LLM annotation propagate into RS, nor does it test whether the optimal resolution is robust to using a weaker LLM backbone or perturbing the annotation step.

- **The RS weight hyperparameter *w* is weakly justified.** The paper states *w* = 1/3 was chosen via "a small grid search" and found to give "stable ordering of resolutions across data sets" — but only one dataset is used. Fig. S5 shows sensitivity to *w*, but no analysis of whether the optimal resolution *r* shifts with *w*, or what range of *w* yields the same choice. For a method that claims objectivity, the dependence on a free parameter needs more thorough characterization.

- **No statistical significance tests.** The RS boxplots (Figs. 3a, 4a) show distributions across clusters, but no hypothesis tests (e.g., Wilcoxon between top resolution and second-best) or confidence intervals are reported. It is unclear whether the peak at r=0.4 is statistically distinguishable from r=0.3 or r=0.5.

- **Missing implementation details in the main text.** The number of marker genes per cluster, the log-fold-change threshold, and whether retrieval tools (GO/KEGG/PubMed) are real-time API calls or local databases are relegated to the appendix. While the appendix exists in the original submission, the main text should at least summarize these key parameters for reproducibility.

### Trivial

- The abstract claims "recovery of known perturbation effects" but no such quantitative recovery is actually measured or shown in the paper. The text should be more carefully scoped to match what is demonstrated.

## Nice-to-Haves

- Runtime and API cost analysis would strengthen the practicality claims ("orders of magnitude faster than manual curation").
- Testing whether a cheaper LLM backbone (GPT-4o, Gemini-2.5-pro) yields the same optimal resolution would demonstrate robustness.
- Direct overlay of RS, silhouette, and modularity curves on the same axes (rather than separate figures) would help the reader compare.

## Removed Points

- *"The paper does not validate that the method works — the evaluation protocol does not measure what it claims to measure."* → Kept and downgraded from the critic's "structural/fatal" framing to Major, because the paper genuinely makes a novel contribution (the idea itself) even if the validation is incomplete; this is fixable with additional experiments, not a fatal design flaw.
- *"Missing comparison with consensus clustering, MultiK."* → Kept as Major.
- *"The enrichment analysis comparison is not a comparison."* → Kept as Major.
- *"No runtime or cost analysis"* → Moved to Nice-to-Haves; this is an incremental improvement, not a core weakness.
- *"Prompt sensitivity / LLM backbone not tested for resolution selection"* → Kept as Minor (partially addressed by Stage 1).
- *"Missing statistical significance"* → Kept as Minor.
- *"The related work reads like a list"* → Removed; this is a subjective presentation nitpick and the related work is actually reasonably thorough.
- *"No ground-truth benchmark"* → Kept as the central Major weakness.
- Strengths removed: *"The problem is important"* (generic, not specific to this paper), *"Direct comparison with three metrics"* (this is true but the comparison doesn't demonstrate superiority — kept but contextualized in weaknesses).

## Novel Insights

None beyond the paper's own contributions. The key observation — that LLM-generated annotation consistency can serve as a resolution-selection criterion — is the paper's own idea and is genuinely novel.

## Suggestions

1. **Add a second dataset with ground-truth labels** (e.g., PBMC with known cell types or a well-annotated Perturb-seq screen). Compute ARI between clusters at each resolution and the ground truth. Show that the resolution maximizing RS achieves higher ARI than resolutions chosen by silhouette or modularity. This single experiment would address the core validation gap.

2. **Add MultiK or another consensus-clustering baseline** to the comparison. Without it, the paper compares against the weakest alternatives.

3. **Report the statistical significance** of the RS difference between the top resolution and its neighbors (e.g., permutation test or Wilcoxon across clusters).

4. **Show the optimal resolution *r* as a function of *w*** over [0,1] to demonstrate stability of the method's recommendation.

## Score and Decision

All anchors retrieved:

| Anchor | Avg Score | Round | Comparison |
|--------|-----------|-------|------------|
| nUpM7egYFd (scMPT) | 3.40 | R1 | Weaker — rejected for unclear LLM contribution; HypoGeneAgent has clearer method |
| 44IKUSdbUD (WDS) | 3.00 | R1 | Much weaker — different topic, low confidence |
| Y9yQ9qmVrc (scKGOT) | 2.50 | R1 | Weaker — rejected for insufficient validation |
| K1bv86Uvbp (LLM Bio KG) | 3.00 | R1 | Weaker — different topic, rejected |
| v7aeTmfGOu (GenoAgent) | 4.00 | R1,R2 | Slightly weaker — similar approach quality, less thorough ablation, also rejected |
| HAwZGLcye3 (BioDiscoveryAgent) | 6.40 | R1,R2 | Stronger — multiple datasets, stronger baselines, accepted |
| J1xtkJmFY3 (ZerOmics) | 4.67 | R1,R2 | Slightly higher — comparable quality, different scope (zero-shot multi-task) |
| jLd7OyAD4Y (LLM4GRN) | 4.33 | R1,R2 | Similar — same validation gap problem (no ground truth), rejected |
| 5WEpbilssv (PerturbQA) | 4.60 | R2 | Slightly higher — mixed reviews, accepted but borderline; HypoGeneAgent has weaker validation |
| RvUVMjfp8i (SSL eval) | 8.00 | R1 | Different topic, much stronger |
| PhRYDGqiee (Image Org) | 5.40 | R2 | Different topic |
| IhD1rBHhDy (Mining Patents) | 5.50 | R2 | Different topic |
| eh1fL0zw8o (LLaPA PPI) | 6.00 | R2 | Different topic, stronger |

**Round 1 bracket**: 4.0–5.5.  
**Round 2 narrowing**: Compared against GenoAgent (4.00, similar weaknesses), LLM4GRN (4.33, similar ground-truth validation gap), PerturbQA (4.60, slightly more complete evaluation). The paper is stronger than GenoAgent and LLM4GRN due to cleaner method and better Stage 1 ablation, but weaker than PerturbQA's more complete benchmark evaluation.  
**Final score**: 4.5.

**Decision rationale**: The paper introduces a genuinely novel idea with a clean formulation and a thorough Stage 1 annotation benchmark. However, the central claim — that the Resolution Score selects biologically better clusterings — is not supported by the evidence presented, which lacks an external ground-truth benchmark, sufficient baselines, and multi-dataset validation. These are structural but remediable gaps; the contribution is real but unsubstantiated in its current form.

<score>4.5</score>
<decision>Reject</decision>